Low molecular weight heparin in hemodialysis patients with a bleeding tendency

Nephron

Volumn 86, Issue 4, 2000, Pages 499-501

  Leu, Jyh Gang ^a,b,c   Chiang, Shou Shan ^a   Lin, Shu May ^a   Pai, Jung Kuei ^a   Jiang, Wey Wen ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Anti factor Xa activity; Antithrombin; Hemodialysis; Low molecular weight heparin; Synthetic membrane

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; DALTEPARIN; HEPARIN; PROTEIN ANTIBODY; THROMBOPLASTIN;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANTICOAGULANTS; ANTITHROMBINS; FACTOR XA; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PARTIAL THROMBOPLASTIN TIME; RENAL DIALYSIS; SERINE PROTEINASE INHIBITORS;

EID: 0034535341     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045840     Document Type: Article

References (8)

1. Effect of high- and low-molecular-weight heparins on thrombin-thrombomodulin interaction and protein C activation
2. Low molecular weight heparins: Practical considerations
3. Low molecular weight heparin in diabetic and nondiabetic hypercholesterolemic patients receiving long-term hemodialysis
4. Use of low-dose low molecular weight heparin in hemodialysis
5. Long-term use of the low molecular weight heparin tinzaparin in haemodialysis
6. Anticoagulants and extracorporeal circuits
7. Dose titration study of tinzaparin, a low molecular weight heparin, in patients on chronic hemodialysis
8. Low-molecular-weight heparins: Pharmacologic profile and product differentiation